COVID-19 CME

COVID-19: Keeping Up With a Moving Target

Released On:
May 1, 2020

Expires On:
May 1, 2021   (Please note that credit will no longer be issued for this activity after this date)

Media Type:
Internet

Completion Time:
2:47 hours

Specialty:
Infectious Disease

Registration Fee: FREE

Credit Available:

• Physicians—2.50 AMA PRA Category 1 Credit(s)™
• Nurses— 3.2 Contact Hours
• Pharmacists — 2.50 hours – The Kentucky Board of Pharmacy has approved this program for 2.5 CE (0.25 CEU) ID number 20-15.
• Respiratory Therapists – This course has been approved by the Kentucky Board of Respiratory Care for 2.5 contact hours. Course number: 20051501

All other health care professionals completing this course will be issued a statement of participation, upon request.

Target Audience:
Local/Regional Physicians, Residents, and other Allied Healthcare Providers

Statement of Need:
COVID-19 is a global pandemic that has already resulted in hundreds of thousands of infections and thousands of deaths, with many more anticipated.

This course will review the current data on emerging novel coronavirus and identification and management of patients exposed to coronavirus.

Speakers:
00:00 – Fadi Al Akhrass, MD, MBA, FACP – Introduction
02:59 – Fadi Al Akhrass, MD, MBA, FACP – COVID 19:  Understanding the Science, Epidemiology, and Clinical Manifestation
16:04 – Muhannad Antoun, MD, FACP – COVID 19:  Understanding the Science, Epidemiology, and Clinical Manifestation
45:26 – C. Chase Reynolds, MD – Cardiac Considerations for COVID-19
56:58 – Hayley, Trimble, MD, FACOG – COVID-19 in Relationship to OB/GYN and Pediatrics
01:04:26 – D. Bradley Akers, MD, FACP – COVID-19 and Pediatrics
01:18:17 – Michael David Cranney, DO – Tracheal intubation of COVID-19 patients
01:28:50 – Ayorinde Medaiyese, MD – Understanding the Pathophysiology and Management of ARDS
02:13:49 – Fadi Al Akhrass, MD, MBA, FACP – Treatment of COVID-19
02:20:12 – Danielle Hamilton, PharmD – Recent COVID-19 Studies
02:25:59 – Ashley Holland, PharmD – Overview of COVID-19 Studies
02:30:55 – Questions and Answers
02:42:55 – Alexis Salyers, DO – Screening Process, Leadership and Development of COVID 19 unit
02:44:55 – Tiffany Salyers, DO – Leadership, Experience and Development of Protocols

Learning Objectives:

• Review epidemiology, clinical manifestations, diagnostics and management of COVID-19
• Discuss how to decrease the nosocomial spread of COVID-19 by following the proper infection prevention measures
• Review COVID-19 infection, transmission, comorbidities and clinical manifestation and laboratories tests
• Appraise how to treat and prevent thrombosis associated with COVID-19
• Appreciate the increased risk of COVID-19 in patients with cardiovascular disease
• Recognize and manage COVID-19 related cardiomyopathy
• Evaluate data on COVID-19- related pregnancy and neonatal outcomes
• Review emerging data on how pediatric patients have been affected by COVID-19
• Discuss the unintended consequences of public health interventions on pediatrics
• Discuss optimizing for successful first-attempt
• Review infection control measures to limit the transmission of COVID-19
• Recognize the effect of COVID-19 on the lungs and in the pathophysiology of ARDS
• Review current management of ARDS in COVID-19 patients and any special circumstances
• Review results of compassionate use or Remdesivir for severe COVID-19
• Analyze the Gilead trial of Remdesivir
• Review the use of Ascorbic Acid and COVID-19
• Review Hydroxychloroquine-Cohort study
• Discuss Hydroxychloroquine and Azithromycin for treatment of COVID-19
• Review the study of Lopinavir-Ritonavir in treatment of COVID-19
• Review protocols developed to address the situation of patients with suspected COVID-19
• Review strategy for patient volume and complexity

Instructions for Participation and Credit

To receive credit you are required to:

• Review video content, https://youtu.be/U_AUGk1D2yQ
• Complete the activity evaluation,
• Score 80% on the required post-test to assess the knowledge gained from reviewing the video,
• Submit the CME/CE registration and evaluation forms.

If you have questions about the participation process, please e-mail CME@pikevillehospital.org or call (606)218-3931.

Accreditation Statement:

Physicians
Pikeville Medical Center is accredited by the Kentucky Medical Association to sponsor continuing medical education for physicians.

Pikeville Medical Center designates this “internet enduring material” for a maximum of 2.50 AMA PRA Category 1 Credits^TM.   Physicians should only claim credits commensurate with the extent of their participation in the activity.

Nurses
Pikeville Medical Center is approved by the Kentucky Board of Nursing as a continuing medical education provider and will award 3.2 nursing contact hours for this program.

KBN provider number 4-0042-12-20-0016 “Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content.”

Pharmacy
The Kentucky Board of Pharmacy has approved this program for 2.5 CE (0.25 CEU) ID number 20-15.

Respiratory
This course has been approved by the Kentucky Board of Respiratory Care for 2.5 contact hours. Course number: 20051501

Disclaimer
The opinions and recommendations expressed by faculty and other experts, whose input is included in this activity, are their own and do not represent Pikeville Medical Center endorsement. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacological therapy to patients.  COVID-19 is an emerging disease. New knowledge is added daily and guidance may change as the situation evolves. Please consult the CDC website regularly for the most up-to-date information.

Special Needs Statement
If you have special needs, please contact our office and we will do our best to accommodate you.

 

Pikeville Medical Center Faculty:
Fadi Al Akhrass, MD, MBA, FACP – Infectious Disease Specialist
Muhannad Antoun, MD, FACP – Infectious Disease Specialist
C. Chase Reynolds, MD – Cardiac Electrophysiologist
Hayley Trimble, MD, FACOG – Obstetrician-Gynecologist
David Bradley Akers ,MD, FAAP – Pediatrician
Michael David Cranney, DO – Anesthesiologist
Ayorinde Medaiyese, MD – Critical Care Specialist
L. Danielle Hamilton, Pharm D. – Clinical Pharmacy Manager
Ashley Holland, Pharm D. – Clinical Pharmacist
Tiffany Salyers, DO – Hospitalist
Alexis Salyers, DO – Hospitalist

Disclosure of Relevant Financial Relationships:
It is the policy at Pikeville Medical Center for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity.  For this purpose, we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

The intend of this policy is to ensure that PMC certified CME activities promote quality, are based on valid content, and are independent of control from commercial interest and free of commercial bias.  Peer review is conducted of all presentations in which faculty disclosed a relevant financial relationship, or speaking off-label.

Faculty Reported Financial Relationship with a commercial interest

Faculty Name                                 Name of Commercial Interest                          Role
Fadi Al Akrass, MD, FACP…………..Glead Sciences, Inc……………………………………….. Speaker
Fadi Al Akrass, MD, FACP…………..Allergan pharmaceuticals……………………………… Advisory Board
C. Chase Reynolds, MD……….………Bristol-Myers Squibb……………………………………. Speaker
C. Chase Reynolds, MD……………….Zoll pharmaceuticals……………………………………. Consultant/Speaker
C. Chase Reynolds, MD………………Abbott pharmaceuticals…………………………….….. Consultant/Speaker

The following Course Faculty and Planning Committee have reported having no relevant financial relationships with any commercial interest related to the content of this educational activity.

Course Faculty:

1. Bradley Akers, MD
2. Michael David Cranney, DO
3. Ayorinde Medaiyese, MD
4. Muhannad Antoun, MD
5. Danielle Hamilton, PharmD
6. Ashley Holland, PharmD
7. Tiffany Salyers, DO
8. Alexis Salyers, DO
9. Hayley Trimble, MD

Planning Committee:

Amanda Benedict, Medical Education Coordinator
Carol Slone, RN Staff Development Specialist
Brenda Adams, Director Continuing Medical Education

Investigational and/or Off-Label Use of Commercial Products or Devices Pikeville Medical Center requires all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation.  Devices or drugs still in clinical trials should be identified as such and should not be portrayed as standard, accepted therapy.

Fadi Al Akhrass, MD, FACP, Danielle Hamilton, PharmD, and Ashley Holland, PharmD have disclosed their presentations will include discussion of off-label, unlabeled, experimental, and/or investigational (not FDA approved), products or procedures.

Commercial Support:  There is no commercial support associated with this activity.

Once you click the "continue" button below, you will be forwarded to a page that will allow you to view the CME course content.

System Requirements:

Your computer must have access to Youtube and be capable of playing Youtube videos.

Important:

After the video, you must successfully complete a 10 question quiz to ensure that you understand the material presented in the seminar. For proof of completion, we strongly suggest you print your test results page as it includes your confirmation number.

Select Video/Course:	Covid-19 CME
First Name
Last Name
Phone
Email Address*
Retype Email Address*